A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-Biologic and/or Biologic DMARDS
Condition: Rheumatoid Arthritis Intervention: Drug: tocilizumab [RoActemra/Actemra] Sponsors: Hoffmann-La Roche; Clalit Health Services Recruiting - verified July 2011